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Risks of getting HIV infections and STIs when traveling to
Latin America
G. Lopardo
FUNCEI, Buenos Aires, Argentina
Sexually transmitted infections (STIs) including HIV infec-
tion are responsible for a variety of acute and chronic
medical problems. Travel may interfere with human sexual
practices by splitting ﬁxed sexual partnerships and remov-
ing social taboos. Increased sexual promiscuity and casual
sexual relationships are likely to occur during travel because
people have the opportunity to escape from standard behav-
iors.
In Latin-American countries (LAC) the prevalence of STIs
is extremely high. Syphilis has a variable prevalence rate
among sex workers in LAC, ranging from 7% in Panama to 29%
in Santos, Brazil. The same applies for gonococcal infections
and other STIs. Resistance rates of Neisseria gonorrhoeae to
different antibiotics vary according to different countries.
Regarding chronic hepatitis B, seroprevalence for different
LAC varies between high-endemicity regions like the Ama-
zon basin, and low and intermediate areas like Argentina
and South Brazil, respectively, determining different risks of
exposure to travelers. There are no vaccines for STIs, with
the exception of those for HBV. It is estimated that in the
Latin American area there are 2 million people living with
HIV and AIDS. Brazil accounts accounts for more than 40%
of total infections. In some Brazilian cities, more than 60%
of drug users are HIV positive. The most severe epidemics
are found in smaller countries such as Belize, Guyana and
Suriname, with HIV prevalence rates of 2.1%, 2.5% and 2.4%
respectively. The majority of countries in the region have
prevalence rates of less than 1%, but the prevalence among
speciﬁc groups, such as men who have sex with men and sex
workers, is often very high. Primary resistance rates of HIV
vary according to the visited area.
Screening of asymptomatic travelers who had casual sex
abroad should be encouraged.
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In Latin America and the Caribbean, 180 million people
ive in poverty, and carry most of the burden of neglected
ropical diseases (NTDs) like soil-transmitted helminthia-
is, schistosomiasis, Chagas disease, lymphatic ﬁlariasis,
nchocerciasis, leishmaniasis, trachoma, rabies, and other
nfections of poverty like neonatal tetanus and congenital
yphilis.
These neglected diseases are often restricted to the rural
nd urban poor and vulnerable and excluded groups like
omen and children, and indigenous communities. They
dversely affect school attendance, children’s physical and
ognitive development, pregnancy outcome, labor produc-
ivity, and/or income-earning capacity, and create social
tigma.
A comprehensive integrated approach with access to
iagnostic and treatment tools and an agenda to address
heir social determinants. Political commitment from mul-
iple sectors is needed to ensure resource availability
nd international support. To facilitate development of
his commitment, the Pan American Health Organization
PAHO)/WHO with its partners have recently taken several
ajor actions. Ten neglected diseases have been mapped
y PAHO in 14 countries for ‘‘hot spots’’. PAHO partnered
ith the Inter-American Development Bank and the Global
etwork for Neglected Tropical Diseases to develop a new
egional Fund for control and elimination of NTDs and other
nfectious diseases of poverty. PAHO’s Directing Council
assed Resolution CD49.R19 (2009) in which Member States
ommitted by 2015 to eliminate or reduce those neglected
iseases for which adequate tools and strategies exist, to
evels in which they are no longer public health problems.
PAHO and partners will complete mapping of the distribu-
ion and overlap of neglected diseases in the Region; develop
vidence-based guidelines and demonstration projects for
ntegrated control; develop models to address social
eterminants; strengthen, scale up and intensify existing
rograms of control and elimination through technical coop-
ration; and plan for certiﬁcation of elimination of diseases
ike onchocerciasis and lymphatic ﬁlariasis which are close
o elimination in the Region.
oi:10.1016/j.ijid.2010.02.1870
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American trypanosomiasis — a zoonotic disease caused
y Trypanosoma cruzi (Protozoa, Kinetoplastida) — is trans-
itted to humans by blood-sucking triatomine bugs, blood
ransfusion and congenital transmission. Successful regional
ector control programs based on the residual application
f insecticide and improved screening of blood donors have
